$GOCO
GoHealth, Inc. Stock $goco

$goco Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000180822024000130 Filed on November 07, 2024

Income Statement

Concept	2024 Q3	2023 Q4
Revenue	$118.3M	$276.7M
YoY Change	-10.41%	298.84%
Cost Of Revenue	$19.68M	$41.09M
YoY Change	-45.31%	99.16%
Gross Profit	$98.61M	$235.6M
YoY Change	2.67%	383.34%
Gross Profit Margin	83.36%	85.15%
Selling, General & Admin	$62.89M	$101.3M
YoY Change	17.34%	22.42%
% of Gross Profit	63.78%	43.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$26.42M	$26.85M
YoY Change	0.45%	1.02%
% of Gross Profit	26.79%	11.4%
Operating Expenses	$141.3M	$210.6M
YoY Change	5.43%	15.93%
Operating Profit	-$42.67M	$25.06M
YoY Change	12.37%	-118.86%
Interest Expense	-$19.09M	-$17.75M
YoY Change	-208.66%	2.51%
% of Operating Profit		-70.83%
Other Income/Expense, Net	-$250.0K	$776.0K
YoY Change	-67.57%	1452.0%
Pretax Income	$15.36M	-$1.915M
YoY Change	-127.27%	-98.73%
Income Tax	-$11.00K	$379.0K
% Of Pretax Income	-0.07%
Net Earnings	$6.775M	-$1.226M
YoY Change	-128.34%	-98.0%
Net Earnings / Revenue	5.73%	-0.44%
Basic Earnings Per Share	$0.58
Diluted Earnings Per Share	$0.46	-$0.13
COMMON SHARES
Basic Shares Outstanding	10.08M shares
Diluted Shares Outstanding	14.58M shares

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$35.53M	$90.81M
YoY Change	34.57%	451.56%
Cash & Equivalents	$35.53M	$90.81M
Short-Term Investments
Other Short-Term Assets	$21.27M	$49.17M
YoY Change	-1.52%	-14.63%
Inventory
Prepaid Expenses
Receivables	$6.862M	$250.0K
Other Receivables	$270.4M	$336.2M
Total Short-Term Assets	$334.0M	$476.4M
YoY Change	-3.54%	14.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.87M	$48.84M
YoY Change	5.31%	4.43%
Goodwill
YoY Change
Intangibles	$326.0M	$396.6M
YoY Change	-24.2%	-20.79%
Long-Term Investments
YoY Change
Other Assets	$2.891M	$2.256M
YoY Change	-0.55%	31.09%
Total Long-Term Assets	$1.007B	$1.023B
YoY Change	-7.7%	-17.8%
TOTAL ASSETS
Total Short-Term Assets	$334.0M	$476.4M
Total Long-Term Assets	$1.007B	$1.023B
Total Assets	$1.341B	$1.500B
YoY Change	-6.7%	-9.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$15.29M	$17.71M
YoY Change	146.02%	16.88%
Accrued Expenses	$49.48M	$86.25M
YoY Change	6.04%	38.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$65.00M	$75.00M
YoY Change		1323.15%
Total Short-Term Liabilities	$282.0M	$370.0M
YoY Change	29.48%	39.39%
LONG-TERM LIABILITIES
Long-Term Debt	$416.3M	$422.7M
YoY Change	-16.23%	-16.26%
Other Long-Term Liabilities	$7.363M	$9.095M
YoY Change	6.96%	-96.94%
Total Long-Term Liabilities	$661.9M	$674.6M
YoY Change	-13.56%	-15.9%
TOTAL LIABILITIES
Total Short-Term Liabilities	$282.0M	$370.0M
Total Long-Term Liabilities	$661.9M	$674.6M
Total Liabilities	$943.9M	$1.045B
YoY Change	-4.03%	-22.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$448.7M	-$420.3M
YoY Change	7.08%	17.72%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$212.0M	$231.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.341B	$1.500B
YoY Change	-6.7%	-9.63%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	$6.775M	-$1.226M
YoY Change	-128.34%	-98.0%
Depreciation, Depletion And Amortization	$26.42M	$26.85M
YoY Change	0.45%	1.02%
Cash From Operating Activities	-$12.23M	$71.30M
YoY Change	-288.11%	-273.91%
INVESTING ACTIVITIES
Capital Expenditures	$4.253M	$5.645M
YoY Change	25.09%	298.66%
Acquisitions
YoY Change
Other Investing Activities	$17.54M
YoY Change
Cash From Investing Activities	$13.28M	-$5.645M
YoY Change	-490.68%	298.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.33M	-1.087M
YoY Change	-1023.95%	-99.31%
NET CHANGE
Cash From Operating Activities	-12.23M	71.30M
Cash From Investing Activities	13.28M	-5.645M
Cash From Financing Activities	20.33M	-1.087M
Net Change In Cash	21.38M	64.57M
YoY Change	2275.89%	-132.45%
FREE CASH FLOW
Cash From Operating Activities	-$12.23M	$71.30M
Capital Expenditures	$4.253M	$5.645M
Free Cash Flow	-$16.48M	$65.66M
YoY Change	-631.61%	-254.79%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity File Number EntityFileNumber	001-39390
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9194000	shares
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-148787000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-36875000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28451000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-61951000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35527000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90809000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	27000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6862000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	250000	usd
CY2024Q3	goco	Contract With Customer Asset After Allowance For Credit Loss Commissions Receivable Current ContractWithCustomerAssetAfterAllowanceForCreditLossCommissionsReceivableCurrent	270383000	usd
CY2023Q4	goco	Contract With Customer Asset After Allowance For Credit Loss Commissions Receivable Current ContractWithCustomerAssetAfterAllowanceForCreditLossCommissionsReceivableCurrent	336215000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21271000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49166000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	334043000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	476440000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	627341000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	575482000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	20449000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	21995000	usd
CY2024Q3	us-gaap	Assets Assets	1341153000	usd
CY2023Q4	us-gaap	Assets Assets	1499570000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	15285000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	17705000	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	49475000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	86254000	usd
CY2024Q3	goco	Contract With Customer Liability Current Commissions Payable ContractWithCustomerLiabilityCurrentCommissionsPayable	80899000	usd
CY2023Q4	goco	Contract With Customer Liability Current Commissions Payable ContractWithCustomerLiabilityCurrentCommissionsPayable	118732000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5541000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5797000	usd
CY2024Q3	goco	Contract With Customer Liability Current Deferred Revenue ContractWithCustomerLiabilityCurrentDeferredRevenue	42696000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	65000000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	23075000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14122000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	281971000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	370013000	usd
CY2024Q3	goco	Contract With Customer Liability Noncurrent Commissions Payable ContractWithCustomerLiabilityNoncurrentCommissionsPayable	177023000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	36187000	usd
	us-gaap	Profit Loss ProfitLoss	-148976000	usd
	dei	Document Type DocumentType	10-Q
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001808220
	dei	Entity Registrant Name EntityRegistrantName	GoHealth, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	118292000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	19683000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	35992000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	78376000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	117876000	usd
CY2024Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	45270000	usd
CY2024Q3	us-gaap	Business Development BusinessDevelopment	45556000	usd
CY2023Q3	us-gaap	Business Development BusinessDevelopment	46472000	usd
	us-gaap	Business Development BusinessDevelopment	132731000	usd
	us-gaap	Business Development BusinessDevelopment	134035000	usd
CY2024Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	9801000	usd
CY2023Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	11652000	usd
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	28921000	usd
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	31706000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17140000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12967000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	50457000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	73440000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23514000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	23514000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	70542000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	70543000	usd
CY2024Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2023Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2687000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	497076000	usd
	us-gaap	Costs And Expenses CostsAndExpenses	554715000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-87314000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-96741000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-250000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-771000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15355000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-108000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8591000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-32294000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	6775000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-23910000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.04
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.61
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10077000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9194000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9489000	shares
CY2024Q3	us-gaap	Profit Loss ProfitLoss	15366000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	143000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	15386000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-56061000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	8602000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-32212000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6784000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23849000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	26843000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	326011000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	396554000	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	132037000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	409762000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	457974000	usd
CY2023Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	39416000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	136049000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	124428000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-332000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-56312000	usd
	us-gaap	Profit Loss ProfitLoss	-148976000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-36857000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-86945000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28437000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62031000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.61
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.14
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9922000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9922000	shares
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-56204000	usd
	us-gaap	Profit Loss ProfitLoss	-65294000	usd
	us-gaap	Profit Loss ProfitLoss	-148976000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-32000	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-86836000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	75000000	usd
CY2023Q4	goco	Contract With Customer Liability Noncurrent Commissions Payable ContractWithCustomerLiabilityNoncurrentCommissionsPayable	203255000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	39547000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	416332000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7363000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	661900000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	50000	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	665020000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-141000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	212040000	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	133219000	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	345259000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1341153000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	4000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3142000	usd
CY2024Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	149000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-739000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-65416000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-149201000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-122000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-225000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	15366000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-56204000	usd
	us-gaap	Profit Loss ProfitLoss	-65294000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.14
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	345259000	usd
	dei	Entity Address Address Line1 EntityAddressAddressLine1	222 W Merchandise Mart Plaza, Suite 1750
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60654
	dei	Entity Address City Or Town EntityAddressCityOrTown	Chicago,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
	dei	City Area Code CityAreaCode	312
	dei	Local Phone Number LocalPhoneNumber	386-8200
	dei	Security12b Title Security12bTitle	Class A Common Stock,$0.0001 par value per share
	dei	Trading Symbol TradingSymbol	GOCO
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	160964000	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	170013000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-42672000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-37976000	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	19086000	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	17565000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	55133000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	51721000	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0563805
CY2024Q3	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	77363000	usd
CY2023Q3	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	usd
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	77363000	usd
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.04
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9489000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14580000	shares
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	189000	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-65326000	usd
CY2024Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	30418000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2891000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2256000	usd
CY2023Q4	goco	Contract With Customer Liability Current Deferred Revenue ContractWithCustomerLiabilityCurrentDeferredRevenue	52403000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	24995000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	0	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	422705000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9095000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	674602000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	50000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	50000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	50000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	654059000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-127000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-448717000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-420280000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	231014000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	174639000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	405653000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1499570000	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	327799000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	15366000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	923000	usd
CY2024Q3	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	0	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	460759000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-56204000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	6000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2173000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	143000	usd
CY2023Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1372000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	892000	usd
CY2023Q3	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	0	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	404613000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	405653000	usd
	us-gaap	Profit Loss ProfitLoss	-65294000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	450000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8688000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-32000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1484000	usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	2722000	usd
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	0	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	345259000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	542399000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	456000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15298000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	189000	usd
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2078000	usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	2675000	usd
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	0	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	404613000	usd
	us-gaap	Profit Loss ProfitLoss	-65294000	usd
	us-gaap	Profit Loss ProfitLoss	-148976000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6534000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15298000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8420000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8357000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	70542000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	70543000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7319000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2397000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2907000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3080000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2687000	usd
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	77363000	usd
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	98000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	636000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4578000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7030000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-104570000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-135636000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-28644000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-34632000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-4268000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-9756000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-44227000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6676000	usd
	goco	Increase Decrease In Contract With Customer Liability Deferred Revenue IncreaseDecreaseInContractWithCustomerLiabilityDeferredRevenue	-9708000	usd
	goco	Increase Decrease In Contract With Customer Liability Deferred Revenue IncreaseDecreaseInContractWithCustomerLiabilityDeferredRevenue	-7775000	usd
	goco	Increase Decrease In Contract With Customer Liability Commissions Payable IncreaseDecreaseInContractWithCustomerLiabilityCommissionsPayable	-64065000	usd
	goco	Increase Decrease In Contract With Customer Liability Commissions Payable IncreaseDecreaseInContractWithCustomerLiabilityCommissionsPayable	-50451000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4976000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-7472000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	9430000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	3982000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-36211000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37840000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	17536000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	11511000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	8087000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6025000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8087000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	50000000	usd
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	15336000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	40000000	usd
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	13584000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1484000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2078000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	2675000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	70000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25064000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20019000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-32000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	189000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-55282000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	9923000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90809000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16464000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	35527000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26387000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	154000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	820000	usd
CY2024Q3	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	state
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make certain estimates, judgments and assumptions that affect the reported amounts of assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting periods. The Company bases its estimates on historical experience and various other assumptions that management believes are reasonable under the circumstances, the results of which form the basis for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2700000	usd
CY2023Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2024Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	10000000.0	usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	10000000.0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	728000000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	474989000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	253011000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	326011000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	728000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	404446000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	323554000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	396554000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	23514000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	94057000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	72800000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	23200000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	23200000	usd
CY2024Q3	goco	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	16240000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	253011000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	11464000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	5091000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	481332000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	497705000	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	65000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	75000000	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	416332000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	422705000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	25000000.0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	416300000	usd
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	goco	Stockholders Equity Note Number Of Shares Of Class A Common Stock Issued To Number Of Llc Interests Owned Required Ratio StockholdersEquityNoteNumberOfSharesOfClassACommonStockIssuedToNumberOfLLCInterestsOwnedRequiredRatio	1
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	day
CY2022Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30	day
CY2022Q3	goco	Debt Covenant Ratio Of Consolidated Total Net Debt To Consolidated Ebitda That Triggers A Preferred Stock Separate Class Vote Trigger DebtCovenantRatioOfConsolidatedTotalNetDebtToConsolidatedEBITDAThatTriggersAPreferredStockSeparateClassVoteTrigger	4
CY2022Q3	goco	Preferred Stock Convertible But Not Converted Calculation Of Purchase Price Percent Of Purchasers Original Investment Amount PreferredStockConvertibleButNotConvertedCalculationOfPurchasePricePercentOfPurchasersOriginalInvestmentAmount	1.600
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2859000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-545000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6534000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16159000	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	15366000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-56204000	usd
	us-gaap	Profit Loss ProfitLoss	-65294000	usd
	us-gaap	Profit Loss ProfitLoss	-148976000	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8591000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-32294000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-36857000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-86945000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	6775000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-23910000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-28437000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62031000	usd
CY2024Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	923000	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	892000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2722000	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	2675000	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5852000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24802000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-31159000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-64706000	usd
CY2024Q3	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	923000	usd
CY2023Q3	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	0	usd
	us-gaap	Convertible Preferred Dividends Net Of Tax ConvertiblePreferredDividendsNetOfTax	0	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6775000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24802000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-31159000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-64706000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10077000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9489000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9922000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9194000	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	424000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2024Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	4079000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14580000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9489000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9922000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9194000	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.61
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.04
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.46
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.61
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.04
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0007
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0019
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0019
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0015
CY2020Q3	goco	Tax Receivable Agreement Payment Amount Percent Of Realized Or Realizable Income Tax Benefits TaxReceivableAgreementPaymentAmountPercentOfRealizedOrRealizableIncomeTaxBenefits	0.85
CY2024Q3	goco	Tax Receivable Agreement Liability TaxReceivableAgreementLiability	800000	usd
CY2023Q4	goco	Tax Receivable Agreement Liability TaxReceivableAgreementLiability	800000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	0	usd
	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	0	usd
	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	0	usd
CY2023Q3	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	0	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	118292000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	132037000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	409762000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	457974000	usd
CY2024Q3	goco	Contract With Customer Asset After Allowance For Credit Loss Unbilled Receivable Current ContractWithCustomerAssetAfterAllowanceForCreditLossUnbilledReceivableCurrent	7200000	usd
CY2023Q4	goco	Contract With Customer Asset After Allowance For Credit Loss Unbilled Receivable Current ContractWithCustomerAssetAfterAllowanceForCreditLossUnbilledReceivableCurrent	36000000.0	usd
CY2024Q3	goco	Contract With Customer Liability Revenue Share ContractWithCustomerLiabilityRevenueShare	10300000	usd
CY2023Q4	goco	Contract With Customer Liability Revenue Share ContractWithCustomerLiabilityRevenueShare	14800000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	7600000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	51100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	45300000	usd
	us-gaap	Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination	90525000	usd
	us-gaap	Contract With Customer Asset Increase Decrease For Contract Acquired In Business Combination ContractWithCustomerAssetIncreaseDecreaseForContractAcquiredInBusinessCombination	0	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1859000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1831000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5806000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5879000	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	9000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	14000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	46000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	47000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	55000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	604000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	326000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	858000	usd
CY2024Q3	us-gaap	Sublease Income SubleaseIncome	689000	usd
CY2023Q3	us-gaap	Sublease Income SubleaseIncome	396000	usd
	us-gaap	Sublease Income SubleaseIncome	1865000	usd
	us-gaap	Sublease Income SubleaseIncome	1181000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	1234000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	2053000	usd
	us-gaap	Lease Cost LeaseCost	4313000	usd
	us-gaap	Lease Cost LeaseCost	5603000	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	2700000	usd
CY2023Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2024Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1990000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	9357000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	8162000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8260000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7296000	usd
CY2024Q3	goco	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	20693000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	55758000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14030000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	41728000	usd
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	2216000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	3075000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	7659000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	10123000	usd
CY2024Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1361000	usd
CY2023Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6735000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1361000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	6735000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M6D
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.092
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.089
CY2024Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	12000000.0	usd
CY2024Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	10500000	usd
CY2024Q3	goco	Related Party Transaction Lease Payments RelatedPartyTransactionLeasePayments	1300000	usd
	goco	Related Party Transaction Lease Payments RelatedPartyTransactionLeasePayments	4300000	usd
CY2023Q3	goco	Related Party Transaction Lease Payments RelatedPartyTransactionLeasePayments	1500000	usd
	goco	Related Party Transaction Lease Payments RelatedPartyTransactionLeasePayments	4500000	usd
CY2022Q3	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	828	position
CY2022Q3	goco	Restructuring And Related Cost Number Of Positions Eliminated Percent Of Workforce RestructuringAndRelatedCostNumberOfPositionsEliminatedPercentOfWorkforce	0.237
	goco	Restructuring Charges Excluding Executive Related Severance Expenses RestructuringChargesExcludingExecutiveRelatedSeveranceExpenses	0	usd
CY2024Q3	goco	Restructuring Charges Excluding Executive Related Severance Expenses RestructuringChargesExcludingExecutiveRelatedSeveranceExpenses	0	usd
	goco	Restructuring Charges Excluding Executive Related Severance Expenses RestructuringChargesExcludingExecutiveRelatedSeveranceExpenses	0	usd
CY2023Q3	goco	Restructuring Charges Excluding Executive Related Severance Expenses RestructuringChargesExcludingExecutiveRelatedSeveranceExpenses	0	usd
CY2023Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	645000	usd
CY2022Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	2083000	usd
	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	558000	usd
	us-gaap	Payments For Restructuring PaymentsForRestructuring	1138000	usd
CY2024Q3	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	87000	usd
CY2023Q3	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	945000	usd
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001808220-24-000130-index-headers.html	Edgar Link	pending
0001808220-24-000130-index.html	Edgar Link	pending
0001808220-24-000130.txt	Edgar Link	pending
0001808220-24-000130-xbrl.zip	Edgar Link	pending
a103-gohealthxamendmentn.htm	Edgar Link	pending
a103-gohealthxamendmentn001.jpg	Edgar Link	pending
a103-gohealthxamendmentn002.jpg	Edgar Link	pending
a103-gohealthxamendmentn003.jpg	Edgar Link	pending
a103-gohealthxamendmentn004.jpg	Edgar Link	pending
a103-gohealthxamendmentn005.jpg	Edgar Link	pending
a103-gohealthxamendmentn006.jpg	Edgar Link	pending
a103-gohealthxamendmentn007.jpg	Edgar Link	pending
a103-gohealthxamendmentn008.jpg	Edgar Link	pending
a103-gohealthxamendmentn009.jpg	Edgar Link	pending
a103-gohealthxamendmentn010.jpg	Edgar Link	pending
a103-gohealthxamendmentn011.jpg	Edgar Link	pending
a103-gohealthxamendmentn012.jpg	Edgar Link	pending
a103-gohealthxamendmentn013.jpg	Edgar Link	pending
a103-gohealthxamendmentn014.jpg	Edgar Link	pending
a103-gohealthxamendmentn015.jpg	Edgar Link	pending
a103-gohealthxamendmentn016.jpg	Edgar Link	pending
a103-gohealthxamendmentn017.jpg	Edgar Link	pending
a103-gohealthxamendmentn018.jpg	Edgar Link	pending
a103-gohealthxamendmentn019.jpg	Edgar Link	pending
a103-gohealthxamendmentn020.jpg	Edgar Link	pending
a104-gohealthxconsentlet.htm	Edgar Link	pending
a104-gohealthxconsentlet001.jpg	Edgar Link	pending
a104-gohealthxconsentlet002.jpg	Edgar Link	pending
a104-gohealthxconsentlet003.jpg	Edgar Link	pending
a104-gohealthxconsentlet004.jpg	Edgar Link	pending
a104-gohealthxconsentlet005.jpg	Edgar Link	pending
a104-gohealthxconsentlet006.jpg	Edgar Link	pending
a104-gohealthxconsentlet007.jpg	Edgar Link	pending
a104-gohealthxconsentlet008.jpg	Edgar Link	pending
a104-gohealthxconsentlet009.jpg	Edgar Link	pending
a104-gohealthxconsentlet010.jpg	Edgar Link	pending
a104-gohealthxconsentlet011.jpg	Edgar Link	pending
a104-gohealthxconsentlet012.jpg	Edgar Link	pending
a104-gohealthxconsentlet013.jpg	Edgar Link	pending
a104-gohealthxconsentlet014.jpg	Edgar Link	pending
a104-gohealthxconsentlet015.jpg	Edgar Link	pending
a104-gohealthxconsentlet016.jpg	Edgar Link	pending
a104-gohealthxconsentlet017.jpg	Edgar Link	pending
a104-gohealthxconsentlet018.jpg	Edgar Link	pending
a105amendedandrestatemen.htm	Edgar Link	pending
a105amendedandrestatemen001.jpg	Edgar Link	pending
a105amendedandrestatemen002.jpg	Edgar Link	pending
a105amendedandrestatemen003.jpg	Edgar Link	pending
a105amendedandrestatemen004.jpg	Edgar Link	pending
a105amendedandrestatemen005.jpg	Edgar Link	pending
a105amendedandrestatemen006.jpg	Edgar Link	pending
a105amendedandrestatemen007.jpg	Edgar Link	pending
a105amendedandrestatemen008.jpg	Edgar Link	pending
a105amendedandrestatemen009.jpg	Edgar Link	pending
a105amendedandrestatemen010.jpg	Edgar Link	pending
a105amendedandrestatemen011.jpg	Edgar Link	pending
a105amendedandrestatemen012.jpg	Edgar Link	pending
a105amendedandrestatemen013.jpg	Edgar Link	pending
a105amendedandrestatemen014.jpg	Edgar Link	pending
a105amendedandrestatemen015.jpg	Edgar Link	pending
a105amendedandrestatemen016.jpg	Edgar Link	pending
a105amendedandrestatemen017.jpg	Edgar Link	pending
a105amendedandrestatemen018.jpg	Edgar Link	pending
a105amendedandrestatemen019.jpg	Edgar Link	pending
a105amendedandrestatemen020.jpg	Edgar Link	pending
a105amendedandrestatemen021.jpg	Edgar Link	pending
a105amendedandrestatemen022.jpg	Edgar Link	pending
a105amendedandrestatemen023.jpg	Edgar Link	pending
a105amendedandrestatemen024.jpg	Edgar Link	pending
a105amendedandrestatemen025.jpg	Edgar Link	pending
a105amendedandrestatemen026.jpg	Edgar Link	pending
a105amendedandrestatemen027.jpg	Edgar Link	pending
a105amendedandrestatemen028.jpg	Edgar Link	pending
a105amendedandrestatemen029.jpg	Edgar Link	pending
a105amendedandrestatemen030.jpg	Edgar Link	pending
a105amendedandrestatemen031.jpg	Edgar Link	pending
a105amendedandrestatemen032.jpg	Edgar Link	pending
a105amendedandrestatemen033.jpg	Edgar Link	pending
a105amendedandrestatemen034.jpg	Edgar Link	pending
a105amendedandrestatemen035.jpg	Edgar Link	pending
a105amendedandrestatemen036.jpg	Edgar Link	pending
a105amendedandrestatemen037.jpg	Edgar Link	pending
a105amendedandrestatemen038.jpg	Edgar Link	pending
a105amendedandrestatemen039.jpg	Edgar Link	pending
a105amendedandrestatemen040.jpg	Edgar Link	pending
a105amendedandrestatemen041.jpg	Edgar Link	pending
a105amendedandrestatemen042.jpg	Edgar Link	pending
a105amendedandrestatemen043.jpg	Edgar Link	pending
a105amendedandrestatemen044.jpg	Edgar Link	pending
a105amendedandrestatemen045.jpg	Edgar Link	pending
a105amendedandrestatemen046.jpg	Edgar Link	pending
a105amendedandrestatemen047.jpg	Edgar Link	pending
a105amendedandrestatemen048.jpg	Edgar Link	pending
a105amendedandrestatemen049.jpg	Edgar Link	pending
a105amendedandrestatemen050.jpg	Edgar Link	pending
a105amendedandrestatemen051.jpg	Edgar Link	pending
a105amendedandrestatemen052.jpg	Edgar Link	pending
a105amendedandrestatemen053.jpg	Edgar Link	pending
a105amendedandrestatemen054.jpg	Edgar Link	pending
a105amendedandrestatemen055.jpg	Edgar Link	pending
a105amendedandrestatemen056.jpg	Edgar Link	pending
a105amendedandrestatemen057.jpg	Edgar Link	pending
a105amendedandrestatemen058.jpg	Edgar Link	pending
a105amendedandrestatemen059.jpg	Edgar Link	pending
a105amendedandrestatemen060.jpg	Edgar Link	pending
a105amendedandrestatemen061.jpg	Edgar Link	pending
a105amendedandrestatemen062.jpg	Edgar Link	pending
a105amendedandrestatemen063.jpg	Edgar Link	pending
a105amendedandrestatemen064.jpg	Edgar Link	pending
a105amendedandrestatemen065.jpg	Edgar Link	pending
a105amendedandrestatemen066.jpg	Edgar Link	pending
a105amendedandrestatemen067.jpg	Edgar Link	pending
a105amendedandrestatemen068.jpg	Edgar Link	pending
a105amendedandrestatemen069.jpg	Edgar Link	pending
a105amendedandrestatemen070.jpg	Edgar Link	pending
a105amendedandrestatemen071.jpg	Edgar Link	pending
a105amendedandrestatemen072.jpg	Edgar Link	pending
a105amendedandrestatemen073.jpg	Edgar Link	pending
a105amendedandrestatemen074.jpg	Edgar Link	pending
a105amendedandrestatemen075.jpg	Edgar Link	pending
a105amendedandrestatemen076.jpg	Edgar Link	pending
a105amendedandrestatemen077.jpg	Edgar Link	pending
a105amendedandrestatemen078.jpg	Edgar Link	pending
a105amendedandrestatemen079.jpg	Edgar Link	pending
a105amendedandrestatemen080.jpg	Edgar Link	pending
a105amendedandrestatemen081.jpg	Edgar Link	pending
a105amendedandrestatemen082.jpg	Edgar Link	pending
a105amendedandrestatemen083.jpg	Edgar Link	pending
a105amendedandrestatemen084.jpg	Edgar Link	pending
a105amendedandrestatemen085.jpg	Edgar Link	pending
a105amendedandrestatemen086.jpg	Edgar Link	pending
a105amendedandrestatemen087.jpg	Edgar Link	pending
a105amendedandrestatemen088.jpg	Edgar Link	pending
a105amendedandrestatemen089.jpg	Edgar Link	pending
a105amendedandrestatemen090.jpg	Edgar Link	pending
a105amendedandrestatemen091.jpg	Edgar Link	pending
a105amendedandrestatemen092.jpg	Edgar Link	pending
a105amendedandrestatemen093.jpg	Edgar Link	pending
a105amendedandrestatemen094.jpg	Edgar Link	pending
a105amendedandrestatemen095.jpg	Edgar Link	pending
a105amendedandrestatemen096.jpg	Edgar Link	pending
a105amendedandrestatemen097.jpg	Edgar Link	pending
a105amendedandrestatemen098.jpg	Edgar Link	pending
a105amendedandrestatemen099.jpg	Edgar Link	pending
a105amendedandrestatemen100.jpg	Edgar Link	pending
a105amendedandrestatemen101.jpg	Edgar Link	pending
a105amendedandrestatemen102.jpg	Edgar Link	pending
a105amendedandrestatemen103.jpg	Edgar Link	pending
a105amendedandrestatemen104.jpg	Edgar Link	pending
a105amendedandrestatemen105.jpg	Edgar Link	pending
a105amendedandrestatemen106.jpg	Edgar Link	pending
a105amendedandrestatemen107.jpg	Edgar Link	pending
a105amendedandrestatemen108.jpg	Edgar Link	pending
a105amendedandrestatemen109.jpg	Edgar Link	pending
a105amendedandrestatemen110.jpg	Edgar Link	pending
a105amendedandrestatemen111.jpg	Edgar Link	pending
a105amendedandrestatemen112.jpg	Edgar Link	pending
a105amendedandrestatemen113.jpg	Edgar Link	pending
a105amendedandrestatemen114.jpg	Edgar Link	pending
a105amendedandrestatemen115.jpg	Edgar Link	pending
a105amendedandrestatemen116.jpg	Edgar Link	pending
a105amendedandrestatemen117.jpg	Edgar Link	pending
a105amendedandrestatemen118.jpg	Edgar Link	pending
a105amendedandrestatemen119.jpg	Edgar Link	pending
a105amendedandrestatemen120.jpg	Edgar Link	pending
a105amendedandrestatemen121.jpg	Edgar Link	pending
a105amendedandrestatemen122.jpg	Edgar Link	pending
a105amendedandrestatemen123.jpg	Edgar Link	pending
a105amendedandrestatemen124.jpg	Edgar Link	pending
a105amendedandrestatemen125.jpg	Edgar Link	pending
a105amendedandrestatemen126.jpg	Edgar Link	pending
a105amendedandrestatemen127.jpg	Edgar Link	pending
a105amendedandrestatemen128.jpg	Edgar Link	pending
a105amendedandrestatemen129.jpg	Edgar Link	pending
a105amendedandrestatemen130.jpg	Edgar Link	pending
a105amendedandrestatemen131.jpg	Edgar Link	pending
a105amendedandrestatemen132.jpg	Edgar Link	pending
a105amendedandrestatemen133.jpg	Edgar Link	pending
a105amendedandrestatemen134.jpg	Edgar Link	pending
a105amendedandrestatemen135.jpg	Edgar Link	pending
a105amendedandrestatemen136.jpg	Edgar Link	pending
a105amendedandrestatemen137.jpg	Edgar Link	pending
a105amendedandrestatemen138.jpg	Edgar Link	pending
a105amendedandrestatemen139.jpg	Edgar Link	pending
a105amendedandrestatemen140.jpg	Edgar Link	pending
a105amendedandrestatemen141.jpg	Edgar Link	pending
a105amendedandrestatemen142.jpg	Edgar Link	pending
a105amendedandrestatemen143.jpg	Edgar Link	pending
a105amendedandrestatemen144.jpg	Edgar Link	pending
a105amendedandrestatemen145.jpg	Edgar Link	pending
a105amendedandrestatemen146.jpg	Edgar Link	pending
a105amendedandrestatemen147.jpg	Edgar Link	pending
a105amendedandrestatemen148.jpg	Edgar Link	pending
a105amendedandrestatemen149.jpg	Edgar Link	pending
a105amendedandrestatemen150.jpg	Edgar Link	pending
a105amendedandrestatemen151.jpg	Edgar Link	pending
a105amendedandrestatemen152.jpg	Edgar Link	pending
a105amendedandrestatemen153.jpg	Edgar Link	pending
a105amendedandrestatemen154.jpg	Edgar Link	pending
a105amendedandrestatemen155.jpg	Edgar Link	pending
a105amendedandrestatemen156.jpg	Edgar Link	pending
a105amendedandrestatemen157.jpg	Edgar Link	pending
a105amendedandrestatemen158.jpg	Edgar Link	pending
a105amendedandrestatemen159.jpg	Edgar Link	pending
a105amendedandrestatemen160.jpg	Edgar Link	pending
a105amendedandrestatemen161.jpg	Edgar Link	pending
a105amendedandrestatemen162.jpg	Edgar Link	pending
a105amendedandrestatemen163.jpg	Edgar Link	pending
a105amendedandrestatemen164.jpg	Edgar Link	pending
a105amendedandrestatemen165.jpg	Edgar Link	pending
a105amendedandrestatemen166.jpg	Edgar Link	pending
a105amendedandrestatemen167.jpg	Edgar Link	pending
a105amendedandrestatemen168.jpg	Edgar Link	pending
a105amendedandrestatemen169.jpg	Edgar Link	pending
a105amendedandrestatemen170.jpg	Edgar Link	pending
a105amendedandrestatemen171.jpg	Edgar Link	pending
a105amendedandrestatemen172.jpg	Edgar Link	pending
a105amendedandrestatemen173.jpg	Edgar Link	pending
a105amendedandrestatemen174.jpg	Edgar Link	pending
a105amendedandrestatemen175.jpg	Edgar Link	pending
a105amendedandrestatemen176.jpg	Edgar Link	pending
a105amendedandrestatemen177.jpg	Edgar Link	pending
a105amendedandrestatemen178.jpg	Edgar Link	pending
a105amendedandrestatemen179.jpg	Edgar Link	pending
a105amendedandrestatemen180.jpg	Edgar Link	pending
a105amendedandrestatemen181.jpg	Edgar Link	pending
a105amendedandrestatemen182.jpg	Edgar Link	pending
a105amendedandrestatemen183.jpg	Edgar Link	pending
a105amendedandrestatemen184.jpg	Edgar Link	pending
a105amendedandrestatemen185.jpg	Edgar Link	pending
a105amendedandrestatemen186.jpg	Edgar Link	pending
a105amendedandrestatemen187.jpg	Edgar Link	pending
a105amendedandrestatemen188.jpg	Edgar Link	pending
a106-amendedandrestatedc.htm	Edgar Link	pending
a106-amendedandrestatedc001.jpg	Edgar Link	pending
a106-amendedandrestatedc002.jpg	Edgar Link	pending
a106-amendedandrestatedc003.jpg	Edgar Link	pending
a106-amendedandrestatedc004.jpg	Edgar Link	pending
a106-amendedandrestatedc005.jpg	Edgar Link	pending
a106-amendedandrestatedc006.jpg	Edgar Link	pending
a106-amendedandrestatedc007.jpg	Edgar Link	pending
a106-amendedandrestatedc008.jpg	Edgar Link	pending
a106-amendedandrestatedc009.jpg	Edgar Link	pending
a106-amendedandrestatedc010.jpg	Edgar Link	pending
a106-amendedandrestatedc011.jpg	Edgar Link	pending
a106-amendedandrestatedc012.jpg	Edgar Link	pending
a106-amendedandrestatedc013.jpg	Edgar Link	pending
a106-amendedandrestatedc014.jpg	Edgar Link	pending
a106-amendedandrestatedc015.jpg	Edgar Link	pending
a106-amendedandrestatedc016.jpg	Edgar Link	pending
a106-amendedandrestatedc017.jpg	Edgar Link	pending
a106-amendedandrestatedc018.jpg	Edgar Link	pending
a106-amendedandrestatedc019.jpg	Edgar Link	pending
a106-amendedandrestatedc020.jpg	Edgar Link	pending
a106-amendedandrestatedc021.jpg	Edgar Link	pending
a106-amendedandrestatedc022.jpg	Edgar Link	pending
a106-amendedandrestatedc023.jpg	Edgar Link	pending
a106-amendedandrestatedc024.jpg	Edgar Link	pending
a106-amendedandrestatedc025.jpg	Edgar Link	pending
a106-amendedandrestatedc026.jpg	Edgar Link	pending
a106-amendedandrestatedc027.jpg	Edgar Link	pending
a106-amendedandrestatedc028.jpg	Edgar Link	pending
a106-amendedandrestatedc029.jpg	Edgar Link	pending
a106-amendedandrestatedc030.jpg	Edgar Link	pending
a106-amendedandrestatedc031.jpg	Edgar Link	pending
a106-amendedandrestatedc032.jpg	Edgar Link	pending
a106-amendedandrestatedc033.jpg	Edgar Link	pending
a106-amendedandrestatedc034.jpg	Edgar Link	pending
a106-amendedandrestatedc035.jpg	Edgar Link	pending
a106-amendedandrestatedc036.jpg	Edgar Link	pending
a106-amendedandrestatedc037.jpg	Edgar Link	pending
a106-amendedandrestatedc038.jpg	Edgar Link	pending
a106-amendedandrestatedc039.jpg	Edgar Link	pending
a106-amendedandrestatedc040.jpg	Edgar Link	pending
a106-amendedandrestatedc041.jpg	Edgar Link	pending
a106-amendedandrestatedc042.jpg	Edgar Link	pending
a106-amendedandrestatedc043.jpg	Edgar Link	pending
a106-amendedandrestatedc044.jpg	Edgar Link	pending
a106-amendedandrestatedc045.jpg	Edgar Link	pending
a106-amendedandrestatedc046.jpg	Edgar Link	pending
a106-amendedandrestatedc047.jpg	Edgar Link	pending
a106-amendedandrestatedc048.jpg	Edgar Link	pending
a106-amendedandrestatedc049.jpg	Edgar Link	pending
a106-amendedandrestatedc050.jpg	Edgar Link	pending
a106-amendedandrestatedc051.jpg	Edgar Link	pending
a106-amendedandrestatedc052.jpg	Edgar Link	pending
a106-amendedandrestatedc053.jpg	Edgar Link	pending
a106-amendedandrestatedc054.jpg	Edgar Link	pending
a106-amendedandrestatedc055.jpg	Edgar Link	pending
a106-amendedandrestatedc056.jpg	Edgar Link	pending
a106-amendedandrestatedc057.jpg	Edgar Link	pending
a106-amendedandrestatedc058.jpg	Edgar Link	pending
a106-amendedandrestatedc059.jpg	Edgar Link	pending
a106-amendedandrestatedc060.jpg	Edgar Link	pending
a106-amendedandrestatedc061.jpg	Edgar Link	pending
a106-amendedandrestatedc062.jpg	Edgar Link	pending
a106-amendedandrestatedc063.jpg	Edgar Link	pending
a106-amendedandrestatedc064.jpg	Edgar Link	pending
a106-amendedandrestatedc065.jpg	Edgar Link	pending
a106-amendedandrestatedc066.jpg	Edgar Link	pending
a106-amendedandrestatedc067.jpg	Edgar Link	pending
a106-amendedandrestatedc068.jpg	Edgar Link	pending
a106-amendedandrestatedc069.jpg	Edgar Link	pending
a106-amendedandrestatedc070.jpg	Edgar Link	pending
a106-amendedandrestatedc071.jpg	Edgar Link	pending
a106-amendedandrestatedc072.jpg	Edgar Link	pending
a106-amendedandrestatedc073.jpg	Edgar Link	pending
a106-amendedandrestatedc074.jpg	Edgar Link	pending
a106-amendedandrestatedc075.jpg	Edgar Link	pending
a106-amendedandrestatedc076.jpg	Edgar Link	pending
a106-amendedandrestatedc077.jpg	Edgar Link	pending
a106-amendedandrestatedc078.jpg	Edgar Link	pending
a106-amendedandrestatedc079.jpg	Edgar Link	pending
a106-amendedandrestatedc080.jpg	Edgar Link	pending
a106-amendedandrestatedc081.jpg	Edgar Link	pending
a106-amendedandrestatedc082.jpg	Edgar Link	pending
a106-amendedandrestatedc083.jpg	Edgar Link	pending
a106-amendedandrestatedc084.jpg	Edgar Link	pending
a106-amendedandrestatedc085.jpg	Edgar Link	pending
a106-amendedandrestatedc086.jpg	Edgar Link	pending
a106-amendedandrestatedc087.jpg	Edgar Link	pending
a106-amendedandrestatedc088.jpg	Edgar Link	pending
a106-amendedandrestatedc089.jpg	Edgar Link	pending
a106-amendedandrestatedc090.jpg	Edgar Link	pending
a106-amendedandrestatedc091.jpg	Edgar Link	pending
a106-amendedandrestatedc092.jpg	Edgar Link	pending
a106-amendedandrestatedc093.jpg	Edgar Link	pending
a106-amendedandrestatedc094.jpg	Edgar Link	pending
a106-amendedandrestatedc095.jpg	Edgar Link	pending
a106-amendedandrestatedc096.jpg	Edgar Link	pending
a106-amendedandrestatedc097.jpg	Edgar Link	pending
a106-amendedandrestatedc098.jpg	Edgar Link	pending
a106-amendedandrestatedc099.jpg	Edgar Link	pending
a106-amendedandrestatedc100.jpg	Edgar Link	pending
a106-amendedandrestatedc101.jpg	Edgar Link	pending
a106-amendedandrestatedc102.jpg	Edgar Link	pending
a106-amendedandrestatedc103.jpg	Edgar Link	pending
a106-amendedandrestatedc104.jpg	Edgar Link	pending
a106-amendedandrestatedc105.jpg	Edgar Link	pending
a106-amendedandrestatedc106.jpg	Edgar Link	pending
a106-amendedandrestatedc107.jpg	Edgar Link	pending
a106-amendedandrestatedc108.jpg	Edgar Link	pending
a106-amendedandrestatedc109.jpg	Edgar Link	pending
a106-amendedandrestatedc110.jpg	Edgar Link	pending
a106-amendedandrestatedc111.jpg	Edgar Link	pending
a106-amendedandrestatedc112.jpg	Edgar Link	pending
a106-amendedandrestatedc113.jpg	Edgar Link	pending
a106-amendedandrestatedc114.jpg	Edgar Link	pending
a106-amendedandrestatedc115.jpg	Edgar Link	pending
a106-amendedandrestatedc116.jpg	Edgar Link	pending
a106-amendedandrestatedc117.jpg	Edgar Link	pending
a106-amendedandrestatedc118.jpg	Edgar Link	pending
a106-amendedandrestatedc119.jpg	Edgar Link	pending
a106-amendedandrestatedc120.jpg	Edgar Link	pending
a106-amendedandrestatedc121.jpg	Edgar Link	pending
a106-amendedandrestatedc122.jpg	Edgar Link	pending
a106-amendedandrestatedc123.jpg	Edgar Link	pending
a106-amendedandrestatedc124.jpg	Edgar Link	pending
a106-amendedandrestatedc125.jpg	Edgar Link	pending
a106-amendedandrestatedc126.jpg	Edgar Link	pending
a106-amendedandrestatedc127.jpg	Edgar Link	pending
a106-amendedandrestatedc128.jpg	Edgar Link	pending
a106-amendedandrestatedc129.jpg	Edgar Link	pending
a106-amendedandrestatedc130.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
goco-20240930.htm	Edgar Link	pending
goco-20240930.xsd	Edgar Link	pending
goco-20240930xex311xform10.htm	Edgar Link	pending
goco-20240930xex312xform10.htm	Edgar Link	pending
goco-20240930xex321xform10.htm	Edgar Link	pending
goco-20240930xex322xform10.htm	Edgar Link	pending
goco-20240930_g1.jpg	Edgar Link	pending
goco-20240930_g2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
goco-20240930_def.xml	Edgar Link	unprocessable
goco-20240930_lab.xml	Edgar Link	unprocessable
goco-20240930_pre.xml	Edgar Link	unprocessable
goco-20240930_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
goco-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GOCO
GoHealth, Inc. Stock $goco

2024 Q3 Form 10-Q Financial Statement

#000180822024000130 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GOCO GoHealth, Inc. Stock $goco

2024 Q3 Form 10-Q Financial Statement

#000180822024000130 Filed on November 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GOCO
GoHealth, Inc. Stock $goco